TLDR:
- Astek Diagnostics received Pre-Series A investment from She’s Independent.
- Other investors included Y Combinator, AYANA Capital, Wexford Scitech Venture Fund, and others.
Astek Diagnostics, a Baltimore-based developer of urine-based diagnostic tools, recently received a Pre-Series A investment from She’s Independent, along with several other investors. The company, led by CEO Mustafa Al-Adhami, is actively working towards FDA marketing authorization for its Jiddu™ Analyzer. They have also initiated collaborations with urology clinics to demonstrate the feasibility of the tool in small clinical studies using real urine specimens. Astek has launched an early access program focused on deploying the Jiddu Analyzer alpha prototype by mid-2024 in select locations. This funding will support the company’s expansion efforts and business reach.
